Christopher Fuller
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 2%
- Infection Control in Healthcare
- SARS-CoV-2 and COVID-19 Research
- Antimicrobial Resistance in Staphylococcus
- COVID-19 Clinical Research Studies
Papers in ⓘ
-
- Infection Control in Healthcare 6
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 3
-
- Health Policy Implementation Science 4
- Co-authors
- Susan Michie (9 shared papers)Andrew Hayward (12 shared papers)Peter E. Reynolds (2 shared papers)B. Cookson (6 shared papers)Ben S. Cooper (4 shared papers)Richard N. Perham (7 shared papers)Sheldon Stone (5 shared papers)Joanne Savage (5 shared papers)
- Journals
- European Journal of Biochemistry (3 papers)BMJ Open (2 papers)The Lancet Healthy Longevity (2 papers)Biochemical Journal (2 papers)Journal of Hospital Infection (2 papers)
- Partner nations
- United KingdomUnited StatesThailand
In The Last Decade
Christopher Fuller
33 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 130
- Applied Microbiology and Biotechnology 105
- Infectious Diseases 672
- General Dentistry 37
- Clinical Biochemistry 135
- Biochemistry 118
Countries citing papers authored by Christopher Fuller
This map shows the geographic impact of Christopher Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Fuller more than expected).
Fields of papers citing papers by Christopher Fuller
This network shows the impact of papers produced by Christopher Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Fuller. The network helps show where Christopher Fuller may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Fuller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 173 | |
| 2 | 2011 | 124 | |
| 3 | 2012 | 121 | |
| 4 | 2021 | 120 | |
| 5 | 1986 | 80 | |
| 6 | 2015 | 78 | |
| 7 | 2021 | 65 | |
| 8 | 1998 | 64 | |
| 9 | 2015 | 62 | |
| 10 | 1991 | 47 | |
| 11 | 2008 | 46 | |
| 12 | 1998 | 46 | |
| 13 | 2005 | 36 | |
| 14 | 2019 | 35 | |
| 15 | 1999 | 34 | |
| 16 | 1996 | 29 | |
| 17 | 1981 | 26 | |
| 18 | 1994 | 24 | |
| 19 | 2013 | 20 | |
| 20 | 2022 | 20 |
About Christopher Fuller
Christopher Fuller is a scholar working on Infectious Diseases, General Health Professions, Clinical Biochemistry, Biochemistry and Applied Microbiology and Biotechnology, having authored 33 papers that have together received 1.4k indexed citations. Recurring topics across this work include Biochemical Acid Research Studies (7 papers), Infection Control in Healthcare (6 papers), Metabolism and Genetic Disorders (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Antibiotic Use and Resistance (5 papers), Health Policy Implementation Science (4 papers), COVID-19 epidemiological studies (4 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (105 citations), Infectious Diseases (672 citations), General Dentistry (37 citations), Clinical Biochemistry (135 citations) and Biochemistry (118 citations). Christopher Fuller has collaborated with scholars based in United Kingdom, United States and Thailand. Frequent co-authors include Susan Michie, Andrew Hayward, Peter E. Reynolds, B. Cookson, Ben S. Cooper, Richard N. Perham, Sheldon Stone, Joanne Savage, Sheldon P. Stone and Sarah Jane Besser. Their work appears in journals such as European Journal of Biochemistry, BMJ Open, The Lancet Healthy Longevity, Biochemical Journal and Journal of Hospital Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.